DOCK3 and Parkinson disease: The clinical outcome measures collected in both the neurologically intact individuals (Healthy Controls; HC) and PD patients from Koch et al. (24) are first reported, with TMTA (Figure 6a; Mann–Whitney U (MWU) = 2583.5, p = 7.683*10−8), TMTB (Figure 6b; MWU = 2651.0, p = 3.967*10−7), MoCA (Figure 6d; MWU = 4913.5, p = 0.0008) and HVLT (Figure 6e; MWU = 6857.5, p = 4.7113*10−5), but not COWAT (Figure 6c; MWU = 5416.5, p = 0.2288) scores differing significantly between the populations.